Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2025 年第 3 季持倉
持倉截至 2025/9/30，2025/11/13 申報。只含多頭部位，變化是跟 2025 年第 2 季比股數。
- 持股檔數
- 86
- 較 2025 年第 2 季 +9
- 總值
- $10.7 億
- 較 2025 年第 2 季 +$3.99 億 (+58.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 625,000 | $6,669 萬 | 6.2% | +15,000+2.5% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 450,000 | $6,480 萬 | 6.0% | −25,000−5.3% | 減碼 | 歷史 |
| SPYSPDR S&P 500 ETF Trust | ETF | 84,490 | $5,629 萬 | 5.2% | +84,490 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,400,000 | $5,621 萬 | 5.2% | +300,000+27.3% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 115,000 | $5,275 萬 | 4.9% | +35,000+43.8% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,173,426 | $4,662 萬 | 4.3% | +481,527+69.6% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 500,000 | $4,105 萬 | 3.8% | +5,000+1.0% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,250,000 | $3,750 萬 | 3.5% | +250,000+25.0% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 384,417 | $3,324 萬 | 3.1% | −30,583−7.4% | 減碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 360,000 | $3,056 萬 | 2.8% | +260,000+260.0% | 加碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 750,000 | $2,844 萬 | 2.6% | −150,000−16.7% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $2,828 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 285,769 | $2,691 萬 | 2.5% | +215,769+308.2% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,107,162 | $2,685 萬 | 2.5% | +207,000+23.0% | 加碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 3,870,527 | $2,570 萬 | 2.4% | +281,172+7.8% | 加碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 2,800,000 | $2,562 萬 | 2.4% | +265,942+10.5% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,419,299 | $2,379 萬 | 2.2% | +812,621+133.9% | 加碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 2,100,000 | $1,974 萬 | 1.8% | −100,000−4.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 350,000 | $1,924 萬 | 1.8% | +350,000 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 959,180 | $1,845 萬 | 1.7% | +355,701+58.9% | 加碼 | 歷史 |
| QUREuniQure N.V. | SHS | 300,000 | $1,751 萬 | 1.6% | +165,000+122.2% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 2,100,000 | $1,537 萬 | 1.4% | +99,692+5.0% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 220,600 | $1,465 萬 | 1.4% | −219,400−49.9% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 200,000 | $1,352 萬 | 1.3% | +200,000 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 1,006,217 | $1,279 萬 | 1.2% | +398,345+65.5% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 310,000 | $1,271 萬 | 1.2% | −24,863−7.4% | 減碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $1,246 萬 | 1.2% | – | – | – |
| VTYXVentyx Biosciences, Inc. | COM | 3,924,415 | $1,220 萬 | 1.1% | −611,767−13.5% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 800,000 | $1,210 萬 | 1.1% | +400,000+100.0% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 500,000 | $1,195 萬 | 1.1% | −470,000−48.5% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 262,100 | $1,031 萬 | 1.0% | +262,100 | 新進 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 3,000,000 | $981.0 萬 | 0.9% | +2,800,000+1,400.0% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 4,285,787 | $934.3 萬 | 0.9% | +200,000+4.9% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 967,620 | $894.1 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 303,330 | $881.5 萬 | 0.8% | −241,670−44.3% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 400,000 | $818.8 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $792.7 萬 | 0.7% | – | – | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,000 | $782.1 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 300,000 | $776.1 萬 | 0.7% | +300,000 | 新進 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 3,600,000 | $766.8 萬 | 0.7% | +100,488+2.9% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 125,000 | $742.9 萬 | 0.7% | +125,000 | 新進 | 歷史 |
| AKBAAkebia Therapeutics, Inc. | COM | 2,450,000 | $668.9 萬 | 0.6% | +500,000+25.6% | 加碼 | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 79,483 | $649.1 萬 | 0.6% | +11,983+17.8% | 加碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 1,274,351 | $551.8 萬 | 0.5% | +1,051,016+470.6% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 250,000 | $539.5 萬 | 0.5% | −140,000−35.9% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 1,500,000 | $535.5 萬 | 0.5% | +1,000,000+200.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 300,000 | $483.6 萬 | 0.4% | +300,000 | 新進 | 歷史 |
| Omeros Corp682143AK8 | NOTE 9.500% 6/1 | – | $471.3 萬 | 0.4% | – | – | – |
| RVMDRevolution Medicines, Inc. | COM | 100,000 | $467.0 萬 | 0.4% | +100,000 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 125,000 | $450.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 245,000 | $419.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Celcuity Inc.15102KAA8 | NOTE 2.750% 8/0 | – | $399.8 萬 | 0.4% | – | 新進 | – |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $375.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 50,000 | $371.0 萬 | 0.3% | +50,000 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,650,000 | $344.5 萬 | 0.3% | +1,982,484+297.0% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 65,000 | $337.6 萬 | 0.3% | −85,000−56.7% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 25,000 | $329.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 75,000 | $312.4 萬 | 0.3% | −77,252−50.7% | 減碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 165,000 | $288.8 萬 | 0.3% | +165,000 | 新進 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,750,000 | $285.3 萬 | 0.3% | −1,295,000−42.5% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 239,000 | $279.4 萬 | 0.3% | +239,000 | 新進 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $266.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,300,000 | $261.3 萬 | 0.2% | −200,000−13.3% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 250,000 | $244.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 350,000 | $240.1 萬 | 0.2% | +350,000 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 300,000 | $218.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 5,000 | $209.6 萬 | 0.2% | +5,000 | 新進 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $205.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 450,000 | $202.5 萬 | 0.2% | +25,000+5.9% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 727,272 | $180.4 萬 | 0.2% | +727,272 | 新進 | 歷史 |
| EPRXEupraxia Pharmaceuticals Inc. | COM | 300,000 | $177.0 萬 | 0.2% | +300,000 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $156.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 666,666 | $133.3 萬 | 0.1% | +666,666 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 200,000 | $114.6 萬 | 0.1% | +200,000 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM NEW | 191,882 | $112.4 萬 | 0.1% | 00.0% | 不變依 1 比 12 拆股換算 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 300,000 | $102.9 萬 | 0.1% | −750,000−71.4% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 752,722 | $65.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 65,317 | $56.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 77,000 | $52.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 402,653 | $39.0 萬 | <0.1% | −115,372−22.3% | 減碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 200,000 | $35.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 17,998 | $21.4 萬 | <0.1% | −262,033−93.6% | 減碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 80,000 | $15.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $5.50 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 2,500 | $2.51 萬 | <0.1% | +2,500 | 新進 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $2,993 | <0.1% | 00.0% | 不變 | – |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | – | $2,952 萬 |
| EXELExelixis, Inc. | COM | $1,446 萬 | $619.5 萬 |
| SMMTSummit Therapeutics Inc. | COM | $723.1 萬 | – |
| NTLAIntellia Therapeutics, Inc. | COM | – | $518.1 萬 |
| OMEROmeros Corp | COM | $464.9 萬 | – |
| OLMAOlema Pharmaceuticals, Inc. | COM | – | $244.8 萬 |
| ATYRaTYR PHARMA INC | COM NEW | $151.5 萬 | – |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | – | $103.1 萬 |
| ABUSArbutus Biopharma Corp | COM | – | $96.0 萬 |
2025 年第 2 季之後清倉（10 檔）
2025 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 2 季股數 | 2025 年第 2 季市值 | 2025 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BPMCBlueprint Medicines Corp | COM | 250,000 | $3,205 萬 | 4.7% | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 1,749,359 | $699.7 萬 | 1.0% | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 50,000 | $522.0 萬 | 0.8% | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 199,643 | $227.0 萬 | 0.3% | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 370,000 | $200.9 萬 | 0.3% | 歷史 |
| NKTXNkarta, Inc. | COM | 800,000 | $132.8 萬 | 0.2% | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 24,692 | $125.7 萬 | 0.2% | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 347,990 | $83.2 萬 | 0.1% | 歷史 |
| RADXRadiopharm Theranostics Ltd | SPONSORED ADS | 35,635 | $16.6 萬 | <0.1% | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $112 | <0.1% | – |